Preparation of Cas9 Ribonucleoproteins for Genome Editing

被引:3
|
作者
Lin, Sheng-Wei [1 ,2 ]
Viet Quoc Nguyen [1 ]
Lin, Steven [1 ,2 ]
机构
[1] Acad Sinica, Inst Biol Chem, Taipei, Taiwan
[2] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan
来源
BIO-PROTOCOL | 2022年 / 12卷 / 10期
关键词
CRISPR; Cas9; RNP; sgRNA; In vitro transcription;
D O I
10.21769/BioProtoc.4420
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genome editing by the delivery of pre-assembled Cas9 ribonucleoproteins (Cas9 RNP) is an increasingly popular approach for cell types that are difficult to manipulate genetically by the conventional plasmid and viral methods. Cas9 RNP editing is robust, precise, capable of multiplexing, and free of genetic materials. Its transient presence in cells limits residual editing activity. This protocol describes the preparation of recombinant Streptococcus pyogenes Cas9 (SpCas9) protein by heterologous expression and purification from Escherichia coli, and the synthesis of CRISPR guide RNA by in vitro transcription and PAGE purification. SpCas9 is the first CRISPR Cas9 discovered (Jinek et al., 2012) and is also one of the most characterized Cas enzymes for genome editing applications. Using this formulation of Cas9 RNP, we have demonstrated highly efficient genome editing in primary human T and natural killer (NK) cells by electroporation, and in fungi and plants by polyethylene glycol-mediated transformation. Our protocol of Cas9 RNP preparation is consistent and straightforward to adopt for genome editing in other cell types and organisms.
引用
收藏
页数:27
相关论文
共 50 条
  • [31] Genome editing via delivery of Cas9 ribonucleoprotein
    DeWitt, Mark A.
    Corn, Jacob E.
    Carroll, Dana
    METHODS, 2017, 121 : 9 - 15
  • [32] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [33] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [34] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [35] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [37] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [38] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [39] Enhanced genome editing with a Streptococcus equinus Cas9
    Liu, Jingtong
    Wang, Yao
    Wei, Jingjing
    Wang, Shengzhou
    Li, Miaomiao
    Huang, Zheyong
    Zhang, Sufang
    Liu, Huihui
    Huang, Jinhai
    Wang, Yongming
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
  • [40] CRISPR/Cas9 editing of the genome for cancer modeling
    Guernet, Alexis
    Grumolato, Luca
    METHODS, 2017, 121 : 130 - 137